Chattem Sanofi Company Profile

✉ Email this page to a colleague

CHATTEM SANOFI has eighteen approved drugs.

There are two US patents protecting CHATTEM SANOFI drugs.

There are sixty-seven patent family members on CHATTEM SANOFI drugs in forty countries and two supplementary protection certificates in two countries.

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Chattem Sanofi	ALLEGRA-D 12 HOUR ALLERGY AND CONGESTION	fexofenadine hydrochloride; pseudoephedrine hydrochloride	TABLET, EXTENDED RELEASE;ORAL	020786-002	Jan 24, 2011		OTC	Yes	Yes		⤷ Subscribe				⤷ Subscribe
Chattem Sanofi	ZANTAC 75	ranitidine hydrochloride	TABLET, EFFERVESCENT;ORAL	020745-001	Feb 26, 1998		DISCN	Yes	No		⤷ Subscribe				⤷ Subscribe
Chattem Sanofi	NICODERM CQ	nicotine	FILM, EXTENDED RELEASE;TRANSDERMAL	020165-005	Aug 2, 1996		OTC	Yes	No		⤷ Subscribe				⤷ Subscribe
Chattem Sanofi	ALLEGRA HIVES	fexofenadine hydrochloride	TABLET;ORAL	020872-008	Jan 24, 2011		DISCN	Yes	No		⤷ Subscribe				⤷ Subscribe
Chattem Sanofi	GAVISCON	aluminum hydroxide; magnesium trisilicate	TABLET, CHEWABLE;ORAL	018685-002	Dec 9, 1983		DISCN	Yes	No		⤷ Subscribe				⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Chattem Sanofi	ALLEGRA-D 24 HOUR ALLERGY AND CONGESTION	fexofenadine hydrochloride; pseudoephedrine hydrochloride	TABLET, EXTENDED RELEASE;ORAL	021704-002	Jan 24, 2011	6,037,353*PED	⤷ Subscribe
Chattem Sanofi	ALLEGRA ALLERGY	fexofenadine hydrochloride	TABLET;ORAL	020872-007	Jan 24, 2011	5,855,912*PED	⤷ Subscribe
Chattem Sanofi	ALLEGRA HIVES	fexofenadine hydrochloride	TABLET;ORAL	020872-009	Jan 24, 2011	6,399,632*PED	⤷ Subscribe
Chattem Sanofi	NICODERM CQ	nicotine	FILM, EXTENDED RELEASE;TRANSDERMAL	020165-004	Aug 2, 1996	8,075,911	⤷ Subscribe
Chattem Sanofi	NICODERM CQ	nicotine	FILM, EXTENDED RELEASE;TRANSDERMAL	020165-006	Aug 2, 1996	9,205,059	⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Oral Suspension	30 mg/5 mL	➤ Subscribe	2010-01-25
➤ Subscribe	Oral Solution	0.5 mg/mL	➤ Subscribe	2009-01-14
➤ Subscribe	Tablets	150 mg	➤ Subscribe	2007-10-30
➤ Subscribe	Transdermal System	7 mg/24 hrs, 14 mg/24 hrs, and 21 mg/24 hrs	➤ Subscribe	2014-05-30
➤ Subscribe	Tablets	5 mg	➤ Subscribe	2007-12-17

Subscribe to access the full database, or Subscribe
Country	Patent Number	Estimated Expiration
European Patent Office	1768649	⤷ Subscribe
Peru	20071003	⤷ Subscribe
South Korea	20080074180	⤷ Subscribe
Norway	339877	⤷ Subscribe
Eurasian Patent Organization	200700067	⤷ Subscribe
>Country	>Patent Number	>Estimated Expiration

Subscribe to access the full database, or Subscribe
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
0058146	2001C/045	Belgium	⤷ Subscribe	PRODUCT NAME: DICHLORHYDRATE DE LEVOCETIRIZINE; NAT RER. NO/DATE: 194 IS 90 F3 20011022; FIRST REG.: DE 49903.00.00 20010103
0663828	C300085	Netherlands	⤷ Subscribe	PRODUCT NAME: LEVOCETIRIZINE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT, IN HET BIJZONDER LEVOCETIRINE DIHYDROCHLORIDE; NAT. REGISTRATION NO/DATE: RVG 26770 20011009; FIRST REGISTRATION: DE 49903.00.00 AND 49904.00.00 20010103
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.